ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 630695 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 630695; 2) Community: the network communities that were significantly associated with the response to NSC 630695; 3) Molecule: the relationships between components within communities and NSC 630695; 4) MDR: the compounds that were significantly associated with the NSC 630695.

NSC Compound Enrichment Correlation
NSC 728037 2-[(3,4-dicloro)anilino]-3-phenyl-5,7-diamino quinoxaline 0.030556149892922 0.26051643
NSC 732837 1-[4-(1-benzyl-4-chloro-2,5-dioxo-2,5-dihydro-1H-3-pyrrolyla mino)phenylcarboxamido]-4-chloro-3-trifluoromethylbenzene 0.030556149892922 0.33324096
NSC 732844 1-[4-(1-benzyl-4-chloro-2,5-dioxo-2,5-dihydro-1H-3-pyrrolyla mino)phenylcarboxamido]-2-fluorobenzene 0.030556149892922 0.32190881
NSC 743862 Null 0.030556149892922 0.33647153
NSC 747174 Null 0.030556149892922 0.25077844
NSC 758682 ARTENIMOL 0.030556149892922 0.33410487
NSC 100880 Camptothecin 0.0348927754043159 0.20338847
NSC 13151 Null 0.0348927754043159 0.28319297
NSC 135687 5.beta.-Bufa-20,22-dienolide, 14,15.beta.-epoxy-3.beta.,5-dihydroxy-, 3-acetate (8CI) 0.0348927754043159 0.21131072
NSC 148790 Card-20(22)-enolide, 16-(acetyloxy)-3,14-dihydroxy-, (3.beta.,5.beta.,16.beta.)- (9CI) 0.0348927754043159 0.13612785
Total:89  Current:55    [First] [Prev] [Next] [Last]